Bronchiolitis / Recurrent Wheezing / Asthmatic bronchitis

Bronchiolitis and recurrent wheezing (asthmatic bronchitis - old name) are very similar lower respiratory tract damage, the only difference being the patient's age: up to 2 years, the diagnosis is bronchiolitis, and over 2 years is diagnosed with recurrent wheezing.

Both conditions are based on bronchial hyperreactivity, i.e. an exaggerated inflammatory response developed by the respiratory tract mucosa, which occurs when it comes into contact with allergens or pathogens such as viruses. In the case of bronchiolitis, the most commonly involved pathogen is the syncytial virus.

The disorder manifests itself by inflammation and edema in the small airways that generate obstruction at this level and consequently respiratory failure.

The latest American neonatology guidelines show that the only effective treatment for bronchiolitis is the administration of aerosols with saline hypertonic solution. SaltMed therapy is much more effective than administering hypertonic saline, for 3 reasons:

• The ability to absorb water, through an osmotic mechanism, of a dry salt particle is greater than that of a drop of hypertonic saline of the same size. Thus, dry salt exerts its mechanism of action more efficiently than the 3% saline hypertonic solution, which already contains 97% water.
• Due to the large amount of water contained, hypertonic saline solutions cannot be distributed in the patient's airways for long periods of time, because too much water would be introduced into the lungs. In contrast, the SaltMed® dry salt inhaler can be used 24/7! This is an advantage for patients with small airway blocked by secretions, whose mucus cloths removal is made step by step and requires a longer time the mucolytic effect to be exerted.
• The number of particles with diameters below 0.5 microns, capable of reaching the alveolar level is much higher in the case of SaltMed than in the case of nebulization of hypertonic solutions, where the average diameters of the particles are 2-3 microns.

SaltMed - natural treatment for Bronchiolitis / Recurrent Wheezing

The dry salt microparticles with controlled characteristics issued by SaltMed act as follows for patients with bronchiolitis and recurrent wheezing:

• Once on the inflamed and edematous respiratory mucosa, salt absorbs water through a simple osmotic process. Water absorption has the effect of decreasing the edema and thereby increase the diameter of the airway lumen.
• Studies also show that, after salt treatment, sensitivity to allergens decreases and local immunity to viral and bacterial infections increases.

Benefits of using SaltMed in children with recurrent wheezing

1. The child's breathing becomes much easier.
2. Prevents new episodes of bronchiolitis and recurrent wheezing and thus the development of asthma - it is known that a large number of bronchiolitis or episodes of recurrent wheezing increases the risk of asthma.
3. SaltMed prevents colds and flu.
4. It’s a natural treatment, without side effects.

How to use SaltMed in patients with bronchiolitis and recurrent wheezing

In the first month, the daily duration of treatment should be around 2 hours a day (but not less than an hour and a half) - to allow salt to take up water from the inflamed mucosa and reduce mucosal edema. We recommend that, in this first stage, SaltMed N-type cartridge to be used.
After the first month, the daily duration of therapy can be reduced to one hour per day and SaltMed cartridge type N or L can be used.
SaltMed therapy for bronchiolitis / recurrent wheezing should be carried out throughout the cold season, starting two weeks before school or kindergarten. In children who also have respiratory allergies, therapy should be continued during the allergy season (May-June). Usually, the therapy is no longer necessary after 2-3 seasons.
There is no risk of overdose with SaltMed therapy and there are no interactions with other drugs. SaltMed therapy is 100% natural and can be done simultaneously with the medicamentous therapy prescribed by the doctor.
In babies it is recommended to be administered while sleeping. For patients over the age of 4 the use of the device is better accepted if the child is provided with additional distraction, such as use of a phone or tablet.